NFKB1 and neoplasm: This could explain the higher expression of GD3S in ER-negative breast cancer cells and tumors, in which the effect of NFκB cannot be repressed by estradiol, leading to a higher amount of complex gangliosides that reinforce proliferative capacity of the tumor.